Guys, found a new consumer product to achieve ejaculatory control – Copy FYI. I’ve been taking it daily for 2 weeks now and it certainly works for me in delaying my time to orgasm. My wife is very pleased that I’m no longer a “sprinter” in bed. Here’s some info.
SEX – CAN IT LAST LONGER ?
THE SOLUTION TO THE MOST COMMON MALE SEXUAL PROBLEM
Consumer Product Developed for Male Climax Control DOVER, Delaware (April 20, 2001) PRNewswire — IDIST Laboratories, LLC announced that it has released for consumer purchase a product that helps promote greater climax (ejaculatory) control in men and allows for longer-lasting and more mutually satisfying sexual intercourse. Deferol Climax Control Supplement is a patent pending, clinically tested product that is the first science-based consumer product to be introduced as a male climax control supplement.
Early ejaculation, premature ejaculation (PE), and lack of ejaculatory control are reported to be the most common sexual difficulties in men. According to American Family Physician, “up to 40% of U.S. males have difficulties with premature ejaculation (PE) or lack of ejaculatory control at some time in their lives”. Other surveys have reported that between 30-60% of men have intermittent concerns about ejaculating too rapidly. Currently, there is no FDA-approved prescription drug for the treatment of premature ejaculation or climax control problems.
“This is a very significant problem affecting at least one-third of all sexually active men,” stated Christopher P. Steidle, M.D., a urologist and leading sexual medicine researcher with Northeast Indiana Research in Fort Wayne. Dr. Steidle is the author of The Impotence Sourcebook, Testosterone — A Users Manual and author of the WellnessWeb.com article Ejaculatory Disorders. “Until the availability of Deferol, the only useful alternative physicians had to offer men with ejaculatory control problems was to prescribe SSRI-type anti-depressant drugs on an off-label basis. Like Deferol, these prescription anti-depressant drugs work by increasing brain serotonin and decreasing anxiety, however, the prescription drugs are not without their drawbacks,” said Dr. Steidle.
As with other types of sexual problems, early ejaculation and a lack of ejaculatory control can cause significant stress and dissatisfaction for both partners and may be disruptive to marriages and other relationships. “A surprising percentage of women complain to their physicians that their partner is unable to perform sexual intercourse for a satisfactory amount of time,” said Dr. Steidle, also co-author of The Female Sexual Dysfunction Treatments. “A man’s lack of ejaculatory control can sometimes undermine an otherwise healthy relationship.”
Initial consumer studies were conducted last year with both “on-demand” (when needed), and chronic daily use of Deferol. In those studies, the intravaginal latency period for ejaculation (time to climax during intercourse) was significantly improved after use of Deferol. David M. Ferguson, Ph.D., M.D., in collaboration with a group of urologists nationwide, plans to conduct additional studies with Deferol. Dr. Ferguson is a prominent medical researcher in Chicago specializing in clinical trial protocol development and has substantial expertise in both male and female sexual medicine research.
“There is strong scientific evidence in the medical literature that supports the Deferol formulation which, by design, utilizes the same proven pathway that prescription SSRI anti-depressants use as part of its activity,” said Dr. Ferguson. “Independent animal laboratory studies have already demonstrated that ingredients in Deferol significantly delay time to ejaculation.”
Deferol was formulated by pharmacists, pharmaceutical scientists, and sexual health researchers, holding U.S. and international patents involving serotonin, to address the principal factors that contribute to a lack of ejaculatory control in men. “Unlike anti-depressants, Deferol was designed to briefly, but naturally, elevate central levels of serotonin and also deliver a specific natural anti-anxiety compound,” said Martin G. Crosby, R.Ph., co-inventor of Deferol. “Together, the proprietary combination of ingredients in Deferol helps to significantly improve ejaculatory control and combat the anxiety that can cause early ejaculation. Deferol’s unique formulation helps delay male sexual climax in a safe, non-prescription manner.”
Deferolis now available to consumers via a confidential purchasing procedure through the Company’s website and through a highly respected consumer health website. Both websites have extensive patient education materials about premature ejaculation and lack of ejaculatory control. Because Deferol is a supplement, obtaining it does not require visiting a physician or obtaining a prescription.
Deferol is the discreet solution to what can be an embarrassing issue for many men. For more information or to purchase Deferol, please visit www.deferol.com, www.wellnessweb.com, or call 1-800-213-0300.
About IDIST Laboratories, LLC IDIST Laboratories, LLC is a science-based consumer products company engaged in commercializing innovative proprietary consumer products to improve quality of life for men and women, with an initial strategic focus on sexual health issues. In addition to Deferol Climax Control Supplement, the Company’s current product development pipeline includes a series of proprietary sexual health and sexual enhancement consumer products.
Deferol Climax Control Supplement is not a drug, and the statements in this press release have not been evaluated by the FDA. Deferol Climax Control Supplement is not intended to diagnose, treat, cure, or prevent any disease. Deferol Climax Control Supplement is a unique natural formulation intended to promote greater climax control in men and allow for longer-lasting sex.